Publiziert in: Marktpuls, Unternehmen
Frei

Save the date: Roche Diagnostics Investor Day 2024 Dienstag, 13. Februar 2024 - 14:07

Investor Update  ?v=11232021124200
Save the date: Roche Diagnostics Investor Day 2024
 

image1.png

 

The Roche Investor Relations team would like to invite you to the Roche Diagnostics Investor Day that will take place in London on Wednesday, 22 May 2024, starting at 12:00 BST local time and will finish at 15:30 BST with a reception.


The Roche Diagnostics Investor Day will address the following topics:

  • Mass spectrometry
  • Continuous glucose monitoring
  • Next generation sequencing
  • Point of care
  • Upcoming molecular diagnostics launches
  • Neurology biomarkers in development


Meeting information:

Date/Time (BST):
Wednesday, 22 May 2024
12:00 - 13:00 Registration and lunch
13:00 - 15:30 Presentations & Q&A
15:30 - 16:15 Reception

Venue
etc.venues 133 Houndsditch
133 Houndsditch
London EC3A 7BX
> map


An invitation with the detailed programme and registration form will soon follow.

Best regards,

 

Bruno Eschli
Head of Investor Relations

 

Birgit Masjost

Investor Relations Officer


Roche Investor Relations

 

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

 

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

 

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

 

 

 

 

Investor Relations North America

 

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com

 

 

 

 

 

All rights reserved ©2023 F. Hoffmann-La Roche Ltd.
Group Communications, Grenzacherstrasse 124, CH-4070 Basel, Switzerland